Oct 1 |
BriaCell Therapeutics Announces $5 Million Offering
|
Oct 1 |
BriaCell dips despite promising mid-stage data for breast cancer therapy
|
Oct 1 |
BriaCell Reports 100% Resolution of Brain Metastasis in Breast Cancer Patient with “Eye-Bulging” Tumor
|
Sep 27 |
What Makes BRIACELL THERAP (BCTX) a New Strong Buy Stock
|
Sep 18 |
BriaCell Announces FDA-Authorized Expanded Access Policy for Metastatic Breast Cancer Patients
|
Sep 12 |
BriaCell Therapeutics Announces Closing of $8.5 Million Offering
|
Sep 11 |
BriaCell Therapeutics Announces US$8.5 Million Share Offering
|
Sep 11 |
BriaCell Therapeutics prices $8.5M equity offering
|
Sep 11 |
BriaCell Therapeutics Announces $8.5 Million Offering
|
Sep 11 |
Why Is Breast Cancer-Focused BriaCell Therapeutics Stock Trading Over 100% On Wednesday
|